Author/Creator: Yoh, K - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Yoh, K

1. 1438PA multicenter single-arm phase II study of nab-paclitaxel/carboplatin for non-small cell lung cancer patients with interstitial lung disease. (23rd October 2018)

Authors:: Usui, Y; Kenmotsu, H; Mori, K; Ono, A; Yoh, K; Baba, T; Fujiwara, Y; Yamaguchi, O; Ko, R; Okamoto, H; Yamamoto, N; Ninomiya, T; Ogura, T; Kato, T
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 1478PEfficacy of second-line nivolumab after early time to progression on first-line cytotoxic chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). (23rd October 2018)

Authors:: Ota, T; Kirita, K; Udagawa, H; Umemura, S; Matsumoto, S; Yoh, K; Niho, S; Goto, K
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. 1487PLURET: Final survival results of the phase II trial of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer. (23rd October 2018)

Authors:: Yoh, K; Seto, T; Satouchi, M; Nishio, M; Yamamoto, N; Murakami, H; Nogami, N; Kuroda, S; Nomura, S; Sato, A; Tsuchihara, K; Kohno, T; Matsumoto, S; Goto, K
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. 414PDPhase I study of the CTLA-4 inhibitor MK-1308 in combination with pembrolizumab in patients with advanced solid tumors. (23rd October 2018)

Authors:: Cho, B C; Perets, R; Bar, J; Ahn, M-J; Kim, D-W; Yoh, K; Nagrial, A; Spigel, D R; Lee, D H; Gutierrez, M; Kotasek, D; Siddiqi, S; Chain, A; Butts, B D; Zhang, Y; Li, X; Cyrus, J; Tse, A; Altura, R A; Rasco, D
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 8
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. 519PInitial results of lung cancer genomic screening project for individualized medicine in Asia: LC-SCRUM-Asia. (24th November 2019)

Authors:: Kuo, C-H S; Yoh, K; Yang, C-T; Wang, C-C; Yen, T-C; Lin, K-J; Ikeda, T; Zenke, Y; Matsumoto, S; Goto, K
Journal:: Annals of oncology
Issue:: Volume 30(2019)Supplement 9
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. 98P Results from a phase I study of MK-1308 (anti–CTLA-4) plus pembrolizumab in previously treated advanced small cell lung cancer. (15th December 2019)

Authors:: Cho, B C; Yoh, K; Bar, J; Nagrial, A; Spigel, D R; Gutierrez, M; Kim, D-W; Kotasek, D; Rasco, D; Niu, J; Satouchi, M; Ahn, M-J; Lee, D H; Maurice-Dror, C; Siddiqi, S; Li, X; Cyrus, J; Altura, R A; Perets, R
Journal:: Annals of oncology
Issue:: Volume 30(2019)Supplement 11
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. T-bet over-expression regulates aryl hydrocarbon receptor-mediated T helper type 17 differentiation through an interferon (IFN)γ-independent pathway. (31st January 2017)

Authors:: Yokosawa, M; Kondo, Y; Tahara, M; Iizuka-Koga, M; Segawa, S; Kaneko, S; Tsuboi, H; Yoh, K; Takahashi, S; Matsumoto, I; Sumida, T
Journal:: Clinical and experimental immunology
Issue:: Volume 188:Number 1(2017:Apr.)
Page Start:: 22
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗